New Agents in Development for Sepsis: Any Reason for Hope? Philippe VignonPierre-François LaterreBruno François Leading Article 20 September 2020 Pages: 1751 - 1761
Pharmacological Management of Glucose Dysregulation in Patients Treated with Second-Generation Antipsychotics Simona CerneaLorena DimaPeter Manu Therapy in Practice 15 September 2020 Pages: 1763 - 1781
First-Line Immune Checkpoint Inhibition for Advanced Non-Small-Cell Lung Cancer: State of the Art and Future Directions Christoph Jakob AckermannHelen AdderleyRaffaele Califano Review Article 28 September 2020 Pages: 1783 - 1797
Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic Agent Mario CazzolaClive PageMaria Gabriella Matera Review Article Open access 06 October 2020 Pages: 1799 - 1809
Targeting HER2 in Breast Cancer: Latest Developments on Treatment Sequencing and the Introduction of Biosimilars Megan E. TeschKaren A. Gelmon Review Article 06 October 2020 Pages: 1811 - 1830
Efficacy of Montelukast in Allergic Rhinitis Treatment: A Systematic Review and Meta-Analysis Madhusudhan KrishnamoorthyNorhayati Mohd NoorBaharudin Abdullah Systematic Review 11 September 2020 Pages: 1831 - 1851
Correction to: Oliceridine: First Approval Anthony Markham Correction 19 October 2020 Pages: 1871 - 1871
Correction to: Triheptanoin: First Approval Matt Shirley Correction Open access 22 October 2020 Pages: 1873 - 1873
